You are here

Innovative 3D Printed Intravaginal Ring AnelleO-PRO, the first Single Administration of Progesterone for Infertility

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41HD100190-01
Agency Tracking Number: R41HD100190
Amount: $174,975.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: NICHD
Solicitation Number: PA18-575
Solicitation Year: 2018
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-09-19
Award End Date (Contract End Date): 2020-08-31
Small Business Information
Chapel Hill, NC 27516-4386
United States
DUNS: 080674215
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 (919) 448-4008
Business Contact
Phone: (919) 448-4008
Research Institution
United States

 Nonprofit College or University

Infertility is a global health problemand in the USmillion women are treated for infertility every yearThere is a strong need to promote patient friendly methods for progesterone supplementation in assisted reproductive technologyARTIntravaginal rings are well tolerated by womenare efficacious for contraception and hormone replacement therapyhave high patient complianceand are now in development for ARTHoweverdeveloping effective IVRs to deliver progesterone beyonddays is challenging due to limitations of current engineering processesand difficulty in controlling release ratesthus mandating drug specific customized IVR designsOur goal is to address these limitations by revolutionizing the engineering and manufacturing processes for intravaginal ringsusing a state of the artD printing process known as continuous liquid interface productionCLIPUsing the automated CLIP processwe can engineer and manufacture IVRs with surface geometries not achievable with traditional injection molding or extrusionwhich help control drug releaseCLIP enables us to precisely fine tune diffusion and release of drugsto achieve near complete releaseand also control IVR mechanical propertiesImportantlyusing CLIP we can manufacture IVRs that provide sustained release of progesterone to cover the entire ART treatment period in a rapid and cost effective single step processIn this Phase I STTR projectbuilding upon our existing datawe propose to use a state of the art engineering processCLIPto develop a highly effective IVRAnelleO PROto deliver progesterone fordays or longerWe will implement comprehensive rational IVR designusing the highly relevant preclinical sheep model to characterize the safety and pharmacokinetic profiles of AnelleO PROThis multidisciplinary cutting edge approach will develop a unique and highly innovativeD printed CLIP IVRdelivering progesterone in longacting single administration treatment of infertility The benefit of sustained release of progesterone to women who undergo infertility treatment is highly significantLong acting intravaginal formulations providing steady release of progesterone over several weeks can increase compliance to ART regimensproviding a patient friendly modality that could transform the ART landscapeThe overarching goal of this proposal is to develop and evaluate an innovative approach to creating and manufacturing intravaginal rings that can contribute to curbing infertilitya significant global medical need

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government